Ischemic Attack, Transient: Clinical Trials

2 recruiting. 2 Phase 3, 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 3	2	Recruiting 2
Phase 2	1	Recruiting 1

Follow Ischemic Attack, Transient: new trials by email Literature Review of Ischemic Attack, Transient trials Research Report on Ischemic Attack, Transient

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke) Tegoprazan 50 mg, Placebo - Ischemic Stroke, Ischemic Stroke, Acute	Phase 3	Recruiting	Hanyang University Guri Hospital	1524	2026-01-26	2026-07-08
Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke Ticagrelor 60 + Aspirin, Ticagrelor 90 + aspirin - Ischemic Stroke, Transient Ischemic Attack	Phase 2 / Phase 3	Recruiting	Mazandaran University of Medical Sciences	100	2024-04-01	2025-04-27

Narrower conditions

Ischemic Stroke (2)  ·  Cerebrovascular Disorders (1)  ·  Gastrointestinal Hemorrhage (1)

Broader conditions

Brain Diseases (2)  ·  Brain Ischemia (2)  ·  Cardiovascular Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Nervous System Diseases (2)  ·  Stroke (2)  ·  Vascular Diseases (2)  ·  Cerebrovascular Disorders (1)  ·  Digestive System Diseases (1)  ·  Gastrointestinal Diseases (1)  ·  Hemorrhage (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Aspirin (1)  ·  tegoprazan (1)

Sponsors

Hanyang University Guri Hospital (1)  ·  Mazandaran University of Medical Sciences (1)

Countries

Iran (1)  ·  South Korea (1)